Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.
2.

Drug metabolism by flavin-containing monooxygenases of human and mouse.

Phillips IR, Shephard EA.

Expert Opin Drug Metab Toxicol. 2017 Feb;13(2):167-181. doi: 10.1080/17425255.2017.1239718. Epub 2016 Sep 29. Review.

PMID:
27678284
3.

Some distinctions between flavin-containing and cytochrome P450 monooxygenases.

Cashman JR.

Biochem Biophys Res Commun. 2005 Dec 9;338(1):599-604. Epub 2005 Aug 11. Review.

PMID:
16112078
4.
5.

Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxide.

Siddens LK, Krueger SK, Henderson MC, Williams DE.

Biochem Pharmacol. 2014 May 1;89(1):141-7. doi: 10.1016/j.bcp.2014.02.006. Epub 2014 Feb 19.

6.

Flavin-containing monooxygenases: mutations, disease and drug response.

Phillips IR, Shephard EA.

Trends Pharmacol Sci. 2008 Jun;29(6):294-301. doi: 10.1016/j.tips.2008.03.004. Epub 2008 Apr 16. Review.

PMID:
18423897
7.

Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism.

Cashman JR.

Curr Drug Metab. 2000 Sep;1(2):181-91. Review.

PMID:
11465082
8.

Genetic polymorphisms of flavin-containing monooxygenase (FMO).

Krueger SK, Williams DE, Yueh MF, Martin SR, Hines RN, Raucy JL, Dolphin CT, Shephard EA, Phillips IR.

Drug Metab Rev. 2002 Aug;34(3):523-32. Review.

PMID:
12214664
9.
10.

The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression.

Hines RN, Cashman JR, Philpot RM, Williams DE, Ziegler DM.

Toxicol Appl Pharmacol. 1994 Mar;125(1):1-6. Review.

PMID:
8128486
11.

An overview of the mechanism, substrate specificities, and structure of FMOs.

Ziegler DM.

Drug Metab Rev. 2002 Aug;34(3):503-11. Review.

PMID:
12214662
12.

Characterization of mouse flavin-containing monooxygenase transcript levels in lung and liver, and activity of expressed isoforms.

Siddens LK, Henderson MC, Vandyke JE, Williams DE, Krueger SK.

Biochem Pharmacol. 2008 Jan 15;75(2):570-9. Epub 2007 Sep 8.

13.

Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.

Zhou J, Shephard EA.

Mutat Res. 2006 Jun;612(3):165-71. Epub 2006 Feb 14. Review.

PMID:
16481213
14.

Developmental regulation of flavin-containing monooxygenase (FMO) isoforms 1 and 2 in pregnant rabbit.

Lee MY, Smiley S, Kadkhodayan S, Hines RN, Williams DE.

Chem Biol Interact. 1995 Apr 28;96(1):75-85.

PMID:
7720106
15.

Measurements of flavin-containing monooxygenase (FMO) activities.

Rose RL.

Curr Protoc Toxicol. 2002 Nov;Chapter 4:Unit4.9. doi: 10.1002/0471140856.tx0409s13.

PMID:
20945301
16.
17.

A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities.

Lawton MP, Cashman JR, Cresteil T, Dolphin CT, Elfarra AA, Hines RN, Hodgson E, Kimura T, Ozols J, Phillips IR, et al.

Arch Biochem Biophys. 1994 Jan;308(1):254-7.

PMID:
8311461
18.

Role of flavin-containing monooxygenase in drug development.

Cashman JR.

Expert Opin Drug Metab Toxicol. 2008 Dec;4(12):1507-21. doi: 10.1517/17425250802522188 . Review.

PMID:
19040327
19.

Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.

Shehin-Johnson SE, Williams DE, Larsen-Su S, Stresser DM, Hines RN.

J Pharmacol Exp Ther. 1995 Mar;272(3):1293-9.

PMID:
7891346
20.

Supplemental Content

Support Center